What ASSEMBLY BIOSCIENCES, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 8 | 13 |
| Total trades | 13 | 29 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 83,335 | 830,033 |
| Disposed | 12,115 | 12,669 |
| Net activity | +71,220 | +817,364 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Bjorkquist Jeanette M | PFO and PAO | Nov 02 | Open-market sale · S | −9 | $20.35 | −$183 | 17,673 |
| Bjorkquist Jeanette M | PFO and PAO | Nov 02 | Open-market sale · S | −718 | $19.61 | −$14.1K | 17,682 |
| Okazaki Jason A | CEO and President | Nov 02 | Open-market sale · S | −69 | $20.35 | −$1.4K | 195,532 |
| Okazaki Jason A | CEO and President | Nov 02 | Open-market sale · S | −6,133 | $19.61 | −$120K | 195,601 |
| White Nicole S | Chief Manufacturing Officer | Nov 02 | Open-market sale · S | −29 | $20.35 | −$590 | 59,257 |
| White Nicole S | Chief Manufacturing Officer | Nov 02 | Open-market sale · S | −2,564 | $19.61 | −$50.3K | 59,286 |
| Gaggar Anuj | Chief Medical Officer | Nov 02 | Open-market sale · S | −29 | $20.35 | −$590 | 53,800 |
| Gaggar Anuj | Chief Medical Officer | Nov 02 | Open-market sale · S | −2,564 | $19.61 | −$50.3K | 53,829 |
| Delaney William E Iv | Chief Scientific Officer | Oct 30 | Grant / award · A | +13,705 | — | — | 74,035 |
| Bjorkquist Jeanette M | PFO and PAO | Oct 30 | Grant / award · A | +3,840 | — | — | 18,400 |
| Okazaki Jason A | CEO and President | Oct 30 | Grant / award · A | +38,380 | — | — | 201,734 |
| White Nicole S | Chief Manufacturing Officer | Oct 30 | Grant / award · A | +13,705 | — | — | 61,850 |
| Gaggar Anuj | Chief Medical Officer | Oct 30 | Grant / award · A | +13,705 | — | — | 56,393 |
| Bjorkquist Jeanette M | PFO and PAO | Jun 17 | Open-market sale · S | −29 | $23.25 | −$674 | 14,560 |
| Gilead SCIENCES, Inc. | 10% owner | May 26 | Grant / award · A | +471,698 | $26.50 | +$12.5M | 4,977,089 |
| White Nicole S | Chief Manufacturing Officer | Mar 30 | Open-market sale · S | −9 | $27.49 | −$247 | 37,477 |
| White Nicole S | Chief Manufacturing Officer | Mar 30 | Open-market sale · S | −188 | $26.65 | −$5.01K | 37,486 |
| Bjorkquist Jeanette M | PFO and PAO | Mar 30 | Open-market sale · S | −16 | $27.49 | −$440 | 11,089 |
| Bjorkquist Jeanette M | PFO and PAO | Mar 30 | Open-market sale · S | −312 | $26.65 | −$8.31K | 11,105 |
| White Nicole S | Chief Manufacturing Officer | Mar 29 | Grant / award · A | +26,000 | — | — | 37,674 |
Loading...